#United States #South San Francisco #gene expression #Plasmidsaurus #RNA-Seq

Plasmidsaurus Unveils Groundbreaking RNA-Seq Service

On October 15, 2025, in a significant leap for gene expression analysis, Plasmidsaurus launched its innovative RNA-Seq service at the American Society of Human Genetics (ASHG) 2025 Annual Meeting. Recognized as a leader in Sequencing as a Service (SaaS), Plasmidsaurus aims to revolutionize the way researchers conduct RNA sequencing. The service provides scientists with a chance to receive in-depth RNA expression profiling with unprecedented speed and convenience.

Transforming Gene Expression Analysis

The RNA-Seq service by Plasmidsaurus stands out due to its remarkable features. Within just three days, researchers can go from basic cell preparations to fully analyzed data—this drastically reduces what typically takes weeks or months with other services. According to Mark Budde, co-founder and CEO of Plasmidsaurus, "Scientists deserve better services. Getting good transcriptomics data shouldn’t take weeks of hassle. Send us cells and we'll get you answers."

Further enhancing accessibility, the service charges only $50 USD per sample for academic institutions and $80 for industry professionals, promising premium accuracy and data quality without compromising affordability. One of the most notable aspects of this service is that it eliminates the need for complex library preparation. Researchers can submit cultured cells in Zymo DNA/RNA shield, allowing room temperature transport via a network of convenient drop-boxes, making the whole process much simpler.

No Need for Bioinformaticians

Plasmidsaurus's RNA-Seq service is designed with user-friendliness in mind. Researchers can create and explore gene expression experiments directly on the results page, completely removing the need for additional bioinformatics support—an aspect that can often overwhelm those without specialized training. There are no minimum order sizes or lengthy quote processes, allowing users to submit as few as one sample or thousands promptly.

Molly Gasperini, Associate Director of Genome Engineering at the Allen Institute and one of the early users of the service, was impressed, stating, "This is SO COOL!!!!! Huge kudos to Plasmidsaurus for this incredibly fast, affordable service. We'll definitely love using this service in the future."

Ideal for Various Research Needs

The Plasmidsaurus RNA-Seq service is designed not only for pharmaceutical and biotech companies seeking rapid feedback on drug candidates or genome editing but also for research labs focusing on gene regulation, cell differentiation, and developmental processes. Furthermore, it is beneficial for any labs needing quick validation of cell line identity and health, making it invaluable in diverse scientific research.

Jim Stapleton, co-founder and CTO of Plasmidsaurus, expressed excitement about the service's potential: "We are continually inspired by our users and the creativity they bring to their experiments. Every day we see how seamless sequencing services unlock new applications, better workflows, and accelerated science. We can't wait to see what researchers can do with faster and more accessible RNA-Seq."

A Busy Launch Experience

Plasmidsaurus will host demonstrations and discussions about the RNA-Seq service during the ASHG 2025 conference in Boston, featuring early-access data and opportunities for interested researchers to pilot the service. Attendees can meet the Plasmidsaurus team during their happy hour on October 15 and attend a presentation on October 16 at 3 PM.

With the introduction of its RNA-Seq service, Plasmidsaurus continues its mission to enhance productivity and innovation among scientists globally. The company aims to accelerate new cures and promote a healthier planet by providing cutting-edge sequencing solutions. To explore Plasmidsaurus RNA-Seq services further, visit www.plasmidsaurus.com/RNA.

About Plasmidsaurus

Plasmidsaurus's services are widely used by a diverse array of innovators, including researchers across universities, biotech startups, pharmaceutical companies, and even DIY biohackers. Their commitment to quality has led to citations in over 2,500 publications to date. Operating a global network of labs around the clock, they are poised to enable world-changing discoveries, fueled by innovation in sequencing technology.